Please login or register first to view this content.
Ophthalmic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Teprotumumab BLA Submitted for Active Thyroid Eye Disease
Several Ophthalmic Products Recalled Due to Possible Sterility Issues
Dextenza Available for Ocular Inflammation, Pain Following Ophthalmic Surgery
Dextenza Approved for Ocular Inflammation Following Ophthalmic Surgery
Eylea Approved for the Treatment of Diabetic Retinopathy
Xeomin Approved as First-Line Treatment for Blepharospasm
Longer Duration of Statin Use Linked to Lower Risk for Glaucoma
Avaclyr Approved for the Treatment of Acute Herpetic Keratitis
Lotemax SM Now Available for Post-Op Ocular Pain and Inflammation
First-of-its-Kind Contact Lens With Faster Light Adaptation Coming Soon
Dexycu Now Available for Treatment of Post-Op Ocular Inflammation
Rocklatan Approved to Reduce IOP in Patients With Open-Angle Glaucoma or Ocular Hypertension
Lotemax SM Approved for Post-Op Inflammation, Pain Following Ocular Surgery
Xipere Under FDA Review for Macular Edema Associated With Uveitis
Yutiq Now Available for Chronic Non-Infectious Posterior Segment Uveitis
USPSTF: Final Rec on Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum
Managing Traumatic Hyphema: Medical Interventions Investigated
Expanding Pharmacist Practice Scope Could Reduce ED Overcrowding
